These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27932582)

  • 1. Safety immunopharmacology: evaluation of the adverse potential of pharmaceuticals on the immune system.
    Descotes J
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):79-83. PubMed ID: 22587937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Justification for species selection for pharmaceutical toxicity studies.
    Prior H; Haworth R; Labram B; Roberts R; Wolfreys A; Sewell F
    Toxicol Res (Camb); 2020 Dec; 9(6):758-770. PubMed ID: 33442468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data science in drug discovery safety: Challenges and opportunities.
    Coltman NJ; Roberts RA; Sidaway JE
    Exp Biol Med (Maywood); 2023 Nov; 248(21):1993-2000. PubMed ID: 38062553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving target assessment in biomedical research: the GOT-IT recommendations.
    Emmerich CH; Gamboa LM; Hofmann MCJ; Bonin-Andresen M; Arbach O; Schendel P; Gerlach B; Hempel K; Bespalov A; Dirnagl U; Parnham MJ
    Nat Rev Drug Discov; 2021 Jan; 20(1):64-81. PubMed ID: 33199880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically Defined Strains in Drug Development and Toxicity Testing.
    Festing MF
    Methods Mol Biol; 2016; 1438():1-17. PubMed ID: 27150081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicology testing in drug discovery and development.
    Dorato MA; Buckley LA
    Curr Protoc Toxicol; 2007 Feb; Chapter 19():Unit19.1. PubMed ID: 23045141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety, efficacy and regulatory triangle in drug development: Impact for animal models and the use of animals.
    van Meer PJ; Graham ML; Schuurman HJ
    Eur J Pharmacol; 2015 Jul; 759():3-13. PubMed ID: 25818943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational Safety Genetics.
    Bhoumik P; Del Rio-Espinola A; Hahne F; Moggs J; Grenet O
    Toxicol Pathol; 2017 Jan; 45(1):119-126. PubMed ID: 27932582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the Genetics and Source of Preclinical Safety Animal Models on Study Design, Results, and Interpretation.
    Colman K
    Toxicol Pathol; 2017 Jan; 45(1):94-106. PubMed ID: 27753639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products.
    Cavagnaro J; Silva Lima B
    Eur J Pharmacol; 2015 Jul; 759():51-62. PubMed ID: 25814257
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.